Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VEZF1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | USP11 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | ZKSCAN2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | LRRC37B | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | GIGYF1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | MAP1B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | PCYT1B | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | VWCE | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
mRNA | LRFN2 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
mRNA | NRSN1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |